Back
ABBV long @ 266.60

Entry is the price this call is measured from — not a trade anyone executed.

243.10 256.41 269.72 283.03 296.34 Aug 27 Sep 14 Sep 29 Oct 14 Oct 29 apesalpha.com ENTRY 266.60
Entry 266.60 At close 290.79 +9.1% vs entry 24 sessions since the post 2026-08-27 → 2026-10-29

Nobody bought this. The long reflects the direction of the call, not a position anyone took, and the figure is measured from where the stock closed on the day it was named — what it cost while the words were said, not a price anyone paid for it.

Named as a final trade on CNBC’s Halftime Report.

  1. The call: on 28 September 2026 (named as “AbbVie”).
  2. The price: The price on this post is ABBV at the moment the post went up, the same entry rule every post here follows.
  3. Source: from the segment “Final Trades: UnitedHealth, AbbVie and Okta”. Watch on CNBC.
  4. Also named in the same segment: UNH at 376.31, OKTA at 201.65.

Risk: a final trade is a pick made on air, and the show does not say who owns what. Nobody disclosed buying it, and the long/short on this post reflects which way the call leaned, not a position anyone took. An automated tracker of public on-air picks, not a recommendation, and not affiliated with CNBC.

· Mon, 28 Sep · · 13 views 10 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.